A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

British Journal of Cancer

Volumn 84, Issue 10, 2001, Pages 1344-1347

  Mononen, N ^a   Ikonen, T ^a   Syrjakoski K ^a   Matikainen, M ^a   Schleutker, J ^a   Tammela, T L J ^a   Koivisto, P A ^a   Kallioniemi, O P ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

5 alpha reductase; A49T; Mutation; Prostate cancer

Indexed keywords

ANDROSTANOLONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; FINLAND; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEGRO; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

CONFIDENCE INTERVALS; FINLAND; GENE FREQUENCY; HUMANS; LINKAGE (GENETICS); MALE; MUTATION, MISSENSE; NEOPLASM STAGING; ODDS RATIO; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TESTOSTERONE 5-ALPHA-REDUCTASE; VARIATION (GENETICS);

EID: 0035906834     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1789     Document Type: Article

References (27)

1. Evidence for a prostate cancer-susceptibility locus on chromosome 20
2. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43
3. Cancer risks in BRCA2 mutation carriers
4. The endocrinology and developmental biology of the prostate
5. Unusual length polymorphism in the human steroid 5 alpha-reductase type 2 gene (SRD5A2)
6. Genetic variation of 3β-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk
7. The V89L Polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer
8. Risks of cancer in BRCA1-mutation carriers
9. Novel inherited mutations and variable expressivity of BRCA I alleles, including the founder mutation 185deIAG in Ashkenazi Jewish families
10. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1 p36
11. Genomic scan of families with prostate cancer identifies multiple regions of interest
12. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
13. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
14. The CAG and GGC Microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer
15. Association of SRD5A2 genotype and pathological characteristics of prostate tumors
16. A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: A case-control analysis
17. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
18. A prevalent missense substitution that modulates activity of prostatic steroid 5α-reductase
19. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA
20. Molecular background of the Finnish disease heritage
21. Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk
22. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
23. A genome wide search reveals a major suceptibility locus for prostate cancer on chromosome 1
24. A genome screen of multiplex sibships with prostate cancer
25. Solid-phase minisequencing as a tool to detect DNA polymorphism
26. Association of prostate cancer with vitamin D receptor gene polymorphism
27. Evidence for a prostate cancer susceptibility locus on the X chromosome